Ignite Creation Date:
2024-05-06 @ 3:32 PM
Last Modification Date:
2024-10-26 @ 1:51 PM
Study NCT ID:
NCT04666922
Status:
COMPLETED
Last Update Posted:
2024-02-23
First Post:
2020-12-09
Brief Title:
A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080
Sponsor:
Boehringer Ingelheim
Organization:
Boehringer Ingelheim
Study Overview
Official Title:
Safety Tolerability Pharmacokinetics and Pharmacodynamics of Single Rising Intravenous Doses of BI 765080 in Healthy Male Subjects Single-blind Randomised Placebo-controlled Parallel-group Design
Status:
COMPLETED
Status Verified Date:
2023-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The main objectives of this trial are to investigate safety tolerability and pharmacokinetics of BI 765080 in healthy male subjects following intravenous administration of single rising doses
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 2020-004262-19 | EUDRACT_NUMBER | None | None |